Why Investors Back Clinical Trials
A guide to how investors think about investing in research for health focused companies
StudySetGo
The research system is broken. I spent 2 years building a system to optimise recruitment, study management, and how industry and researchers work together. Industry gets product validation. Researchers get funding. Only actionable strategies and insights.
Live Last read · last published · next check
Latest posts
How to make your clinical trials assets and not liabilities
Not all commercial nutrition clinical trials are created equally… and some could even do more harm than good
Clinical Evidence Is a Bargaining Chip. Don't Fold It Early.
How (gold-standard) clinical trials can help you get the deal done and be your key to a crazy exit valuation.
5 things to know before commissioning your first clinical trial
If you like the idea of becoming a more evidence based brand but you haven't taken the first steps just yet, here are some practical tips to get ready on your evidence building journey
How to Commission Clinical Trials that Sell + Increases Valuation
Many clinical trials commissioned by supplement and nutrition brands don’t move the needle, here's how to do it creates ROI.
How to Get an Exit as a Nutrition Brand: Clinical Trials Edition
Why you've been thinking about Clinical Trials the wrong way
What KSM-66 figured out that most supplement brands haven't
People don’t buy on emotion. People don’t buy on evidence either. People buy when they have both. And if your brand only offers one, they’ll go and buy from the competitor that offers both.
Your Next Trial Doesn’t Have to Take Three Years
6 to 9 months from first call to published data, stage by stage. What happens in each window. What speeds it up. What causes delays, and how to avoid them.
Why decentralised trials now produce better data than the lab
The research model you choose is a commercial decision before it’s a scientific one. Here’s why you should care about the difference.
Your Ad Account Doesn’t Have a Copy Problem. It Has an Evidence Problem.
Why Google and Meta suspend supplement ad accounts, and what separates the brands that get pulled from the ones that don't.